Posted on 06/21/2009 9:52:00 PM PDT by Steelfish
Experimental drug saves two men with inoperable prostate cancer
By FIONA MACRAE 21st June 2009
Two men with inoperable prostate cancer have made dramatic recoveries after being given a single dose of an experimental drug.
Both men are now cancer-free and their doctors say their progress has exceeded all their expectations.
Dr Eugene Kwon, of the respected Mayo Clinic in Minnesota, said: 'This is one of the Holy Grails of prostate cancer research. We have been looking for this for many years.'
Prostate cancer is the most common cancer in British men, with nearly 35,000 cases a year, 10,000 deaths and few treatments for advanced disease.
The two patients were taking part in a trial involving a drug called ipilimumab, a specially-engineered antibody that boosts the immune system's ability to fight cancer.
Both had late-stage cancer, that had spread beyond the prostate, with one blighted by a tumour the size of a golf ball. Patients in such a condition may only have months to live and are usually offered only palliative care.
The pair were given conventional drugs to mop up the male hormones that fuel the growth of prostate cancer, followed by a single dose of ipilimumab.
(Excerpt) Read more at dailymail.co.uk ...
Inadvertently this was sourced as from the Daily Mirror. It is from the Daily Mail.
Yet another reason why we need to destroy private medicine.
Oh, wait a second....
Good news ping,
Does this mean that a similar effect could be had on breast cancer which is driven by the estrogen hormone? Has research been done for women with breast cancer using ipilimumab?
Wow, a cure is just around the corner...
again.
I tell people that want socialized medicine to tell me the last drug or cure that has come from Canada or Britain. The ratio is about 100 to one from America.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.